Tucatinib early access
 

Hi all,
Given the benefit tucatinib demonstrated in patients with brain mets, I wanted to flag a trial protocol out of Seattle Genetics which is designed to provide tucatinib (possibly with trastuzumab + chemo) ahead of the anticipated FDA formal approval.
https://clinicaltrials.gov/ct2/show/NCT04220203

Wishing a happy and healthy 2020 to everybody.